Medical and Pharmaceutical Roche secures rights to Chinese biotech company’s small cell lung cancer drug Innovent Biologics will receive up to US$1 billion in milestone payments and royalties Rowan DunneJanuary 3, 2025
Health & Wellness Poseida Therapeutics shares skyrocket on acquisition from pharma-giant Roche Poseida's proprietary non-viral gene engineering technology has delivered promising early clinical results Joseph MortonNovember 26, 2024